Patient-derived xenografts for childhood solid tumors: a valuable tool to test new drugs and personalize treatments.

作者: P. Zarzosa , N. Navarro , I. Giralt , C. Molist , A. Almazán-Moga

DOI: 10.1007/S12094-016-1557-2

关键词:

摘要: The use of preclinical models is essential in translational cancer research and especially important pediatric given the low incidence each particular type cancer. Cell line cultures have led to significant advances biology. However, cell lines adapted growth artificial culture conditions, thereby undergoing genetic phenotypic changes which may hinder application. Tumor grafts developed mice from patient tumor tissues, generally known as patient-derived xenografts (PDXs), are interesting alternative approaches reproducing biology original tumor. This review focused on highlighting interest PDX supporting strategies personalized medicine. provides: (1) a description background cancer, (2) case (3) how can improve medicine strategies, (4) new methods increase engraftment, and, finally, (5) concluding remarks.

参考文章(46)
Michael R. Boyd, The NCI In Vitro Anticancer Drug Discovery Screen Anticancer Drug Development Guide. pp. 23- 42 ,(1997) , 10.1007/978-1-4615-8152-9_2
H. H. Fiebig, H. A. Neumann, H. Henß, H. Koch, D. Kaiser, H. Arnold, Development of Three Human Small Cell Lung Cancer Models in Nude Mice Recent results in cancer research. ,vol. 97, pp. 77- 86 ,(1985) , 10.1007/978-3-642-82372-5_8
John M. Venditti, Robert A. Wesley, Jacqueline Plowman, Current NCI preclinical antitumor screening in vivo: results of tumor panel screening, 1976-1982, and future directions. Advances in pharmacology. ,vol. 20, pp. 1- 20 ,(1984) , 10.1016/S1054-3589(08)60263-X
Peter J. Houghton, Janet A. Houghton, Alexander A. Green, Chemotherapy of Childhood Rhabdomyosarcomas Growing as Xenografts in Immune-deprived Mice Cancer Research. ,vol. 42, pp. 535- 539 ,(1982)
Peter J Houghton, Christopher L Morton, Chandra Tucker, Debbie Payne, Edward Favours, Claire Cole, Richard Gorlick, E Anders Kolb, Wendong Zhang, Richard Lock, Hernan Carol, Mimi Tajbakhsh, C Patrick Reynolds, John M Maris, Joshua Courtright, Stephen T Keir, Henry S Friedman, Charles Stopford, Joseph Zeidner, Jianrong Wu, Tiebin Liu, Catherine A Billups, Javed Khan, Sherry Ansher, Jian Zhang, Malcolm A Smith, None, The pediatric preclinical testing program: description of models and early testing results. Pediatric Blood & Cancer. ,vol. 49, pp. 928- 940 ,(2007) , 10.1002/PBC.21078
M J Peckham, J F Smyth, G G Steel, A J Shorthouse, The therapeutic response of bronchial carcinoma xenografts: a direct patient-xenograft comparison. The British journal of cancer. Supplement. ,vol. 4, pp. 142- 145 ,(1980)
David J. Monsma, David M. Cherba, Patrick J. Richardson, Sean Vance, Sanjeet Rangarajan, Dawna Dylewski, Emily Eugster, Stephanie B. Scott, Nicole L. Beuschel, Paula J. Davidson, Richard Axtell, Deanna Mitchell, Eric P. Lester, Joseph J. Junewick, Craig P. Webb, Noel R. Monks, Using a rhabdomyosarcoma patient-derived xenograft to examine precision medicine approaches and model acquired resistance. Pediatric Blood & Cancer. ,vol. 61, pp. 1570- 1577 ,(2014) , 10.1002/PBC.25039
Noémie Braekeveldt, Caroline Wigerup, David Gisselsson, Sofie Mohlin, My Merselius, Siv Beckman, Tord Jonson, Anna Börjesson, Torbjörn Backman, Irene Tadeo, Ana P. Berbegall, Ingrid Öra, Samuel Navarro, Rosa Noguera, Sven Påhlman, Daniel Bexell, Neuroblastoma Patient-Derived Orthotopic Xenografts Retain Metastatic Patterns and Geno- and Phenotypes of Patient Tumours. International Journal of Cancer. ,vol. 136, pp. 252- 261 ,(2015) , 10.1002/IJC.29217
Alexandre de la Fuente, Lorena Alonso-Alconada, Clotilde Costa, Juan Cueva, Tomas Garcia-Caballero, Rafael Lopez-Lopez, Miguel Abal, M-Trap: Exosome-Based Capture of Tumor Cells as a New Technology in Peritoneal Metastasis Journal of the National Cancer Institute. ,vol. 107, ,(2015) , 10.1093/JNCI/DJV184
Sumithra J. Mandrekar, Paul Haluska, Amira A. Zayed, Molecular and clinical implementations of ovarian cancer mouse avatar models Chinese clinical oncology. ,vol. 4, pp. 30- 30 ,(2015) , 10.3978/J.ISSN.2304-3865.2015.04.01